Aberrant DNA methylation had been reported to contribute to tumor progression, accordingly, the promoter DNA methylation levels of CDC25 family members were analyzed using the UCSC Xena database, which revealed a common alteration in three cancer types: KIRP, LUSC, and PRAD (Fig. S3, p < 0.05). This evidence concerns the gene CDC25C and neoplasm.